Sutro Biopharma, Inc.
STRONasdaqCIK 1382101HealthcareFiscal year ends Dec 31
Reports and events: 136 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1207:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-345748 |
| 2026-08-1207:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-345733 |
| 2026-06-0816:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-261658 |
| 2026-05-1416:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224170 |
| 2026-05-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224065 |
| 2026-04-2216:05 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001193125-26-170354 |
| 2026-03-2316:44 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-119873 |
| 2026-03-2316:32 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-119844 |
| 2026-02-1017:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-044934 |
| 2025-12-1716:38 ET | 8-K | 8.01 Other events | 0001193125-25-322859 |
| 2025-12-0316:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-306786 |
| 2025-11-0617:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-270036 |
| 2025-11-0616:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269833 |
| 2025-09-2917:15 ET | 8-K | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001193125-25-223434 |
| 2025-08-0717:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105219 |
| 2025-08-0716:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105159 |
| 2025-06-2516:30 ET | 8-K | 3.01 Delisting notice | 0000950170-25-089978 |
| 2025-06-1016:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-138481 |
| 2025-06-0216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-133268 |
| 2025-05-0816:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067072 |
| 2025-05-0816:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067061 |
| 2025-04-2516:30 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0000950170-25-058774 |
| 2025-04-1416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-053733 |
| 2025-03-1317:17 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-038884 |
| 2025-03-1317:14 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-038879 |
| 2024-12-1008:00 ET | 8-K | 8.01 Other events | 0000950170-24-134765 |
| 2024-11-1316:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126407 |
| 2024-11-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126382 |
| 2024-08-1316:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096336 |
| 2024-08-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096313 |
| 2024-08-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-095486 |
| 2024-06-1016:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-071335 |
| 2024-05-1316:34 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058718 |
| 2024-05-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058701 |
| 2024-04-2616:30 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0000950170-24-049207 |
| 2024-04-0217:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-040345 |
| 2024-04-0206:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-039736 |
| 2024-03-2516:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-035949 |
| 2024-03-2516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-035948 |
| 2024-02-0916:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-030094 |
| 2024-01-0807:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002690 |
| 2023-11-2716:05 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-23-066112 |
| 2023-11-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-065482 |
| 2023-11-1316:32 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063037 |
| 2023-11-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-063021 |
| 2023-10-0416:31 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-23-051917 |
| 2023-08-1016:33 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041416 |
| 2023-08-1016:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041404 |
| 2023-06-2608:01 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-23-029731 |
| 2023-06-1416:31 ET | 8-K | 1.02 Termination of a material agreement; 5.07 Shareholder vote results | 0000950170-23-027975 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.